Randomized, double-masked trial of netarsudil 0.02% ophthalmic solution for prevention of corticosteroid-induced ocular hypertension

To assess whether prophylactic use of netarsudil 0.02% ophthalmic solution reduces the risk of intraocular pressure (IOP) elevation associated with prolonged use of topical corticosteroids to prevent cornea transplant rejection.

Source: American Journal of Ophthalmology - October 9, 2020 Category: Opthalmology Authors: Marianne O. Price, Matthew T. Feng, Francis W. Price Tags: Original Articles Source Type: research